Nova Leap Health Corp. (TSXV:NLH)
Canada · Delayed Price · Currency is CAD 0.5300
0.00 (0.00%)
Sep 14, 2026, 9:30 AM EST
Nova Leap Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 33.6 | 31.47 | 25.76 | 26.18 | 28.21 | 21.28 |
Revenue Growth | 19.53% | 22.15% | -1.60% | -7.18% | 32.55% | 22.93% |
Gross Profit Gross Profit Growth | 13.41 | 12.48 | 9.89 | 9.77 | 9.98 | 7.21 |
Operating Income Operating Income Growth | 1.73 | 1.11 | 0.86 | 0.46 | -1.06 | -1.23 |
Net Income Net Income Growth | 1.35 | -0.19 | 1.38 | -1.05 | -0.84 | 1.76 |
Earnings Per Share EPS Growth | 0.02 | -0.00 | 0.02 | -0.01 | -0.01 | 0.02 |
EPS Growth | 1016.64% | - | - | - | - | 3.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 25.47 | 24.68 | 21.87 | 22.65 | 24.13 | 17.14 |
Canada Canada Growth | 8.13 | 6.79 | 3.88 | 3.52 | 4.07 | 4.12 |
Group Head Office Group Head Office Growth | - | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Total Growth | 33.6 | 31.47 | 25.76 | 26.18 | 28.21 | 21.28 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1.44 | 1.49 | 1.4 | 0.89 | 1.27 | 1.73 |
Total Debt Total Debt Growth | 4.45 | 2.93 | 2.53 | 1.4 | 3.97 | 6.2 |
Net Cash (Debt) Net Cash Growth | -3.01 | -1.44 | -1.12 | -0.5 | -2.69 | -4.47 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.03 | -0.02 | -0.01 | -0.01 | -0.03 | -0.06 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2.05 | 1.56 | 1.39 | 2.15 | 1.02 | 2.18 |
Capital Expenditures CapEx Growth | - | - | -0.03 | -0.03 | -0.07 | - |
Free Cash Flow Free Cash Flow Growth | 2.05 | 1.56 | 1.36 | 2.13 | 0.95 | 2.18 |
Free Cash Flow Growth | 45.53% | 14.19% | -35.91% | 123.97% | -56.44% | -27.47% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.92% | 39.67% | 38.38% | 37.31% | 35.37% | 33.89% |
Operating Margin | 5.14% | 3.52% | 3.35% | 1.76% | -3.77% | -5.79% |
Pretax Margin | 5.54% | -0.42% | 7.03% | -5.22% | -4.28% | 11.62% |
Profit Margin | 4.01% | -0.60% | 5.35% | -4.03% | -2.96% | 8.27% |
FCF Margin | 6.11% | 4.95% | 5.29% | 8.12% | 3.37% | 10.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.83 | - | 11.89 | - | - | 21.71 |
Forward PE | - | 18.95 | 18.95 | 6.05 | 6.16 | 16.07 |
P/FCF Ratio | 16.20 | 11.46 | 12.02 | 9.21 | 16.77 | 17.53 |
PS Ratio | 0.97 | 0.57 | 0.64 | 0.75 | 0.56 | 1.80 |